Fresenius

DGAP-News: Fresenius Medical Care AG & Co. KGaA reports results in line with expectations for the second quarter and confirms 2021 outlook

Friday, July 30, 2021 - 6:53pm

Based on the results for the second quarter and first half, Fresenius Medical Care confirms its outlook for FY 2021 as outlined in February.

Key Points: 
  • Based on the results for the second quarter and first half, Fresenius Medical Care confirms its outlook for FY 2021 as outlined in February.
  • Sustainability is an integral part of Fresenius Medical Care's mission and vision and is reflected in the corporate strategy.
  • These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Option Care Health Appoints Dr. Seema Kumbhat to the Position of Chief Medical Officer

Wednesday, July 28, 2021 - 2:00pm

BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the Company or Option Care Health)(Nasdaq: OPCH), the nations largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer.

Key Points: 
  • BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the Company or Option Care Health)(Nasdaq: OPCH), the nations largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer.
  • Prior to joining Option Care Health, Dr. Kumbhat served as Senior Vice President and Regional Medical Officer for Fresenius Kabi.
  • As a physician, she brings a wealth of knowledge to the Option Care Health team, and Im confident she will make a positive impact in continuing efforts to elevate patient care, John Rademacher, Chief Executive Officer, commented.
  • Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates.

Fresenius Medical Care North America Announces New President for Renal Therapies Group

Thursday, July 22, 2021 - 6:00pm

WALTHAM, Mass., July 22, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company's Renal Therapies Group.

Key Points: 
  • WALTHAM, Mass., July 22, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company's Renal Therapies Group.
  • Turk succeeds Mark Costanzo, who recently retired as President of FMCNA's Renal Therapies Group.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
  • Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent.

UPS Healthcare Announces Agreement With Fresenius Medical Care, Expanding Service In The UK

Thursday, July 22, 2021 - 6:00am

Through this agreement, Polar Speed will assume operation of Fresenius Medical Care's facility in Huthwaite, Nottinghamshire, UK, adding to Polar Speed's GDP-compliant depot network.

Key Points: 
  • Through this agreement, Polar Speed will assume operation of Fresenius Medical Care's facility in Huthwaite, Nottinghamshire, UK, adding to Polar Speed's GDP-compliant depot network.
  • Wes Wheeler, President of UPS Healthcare, said, "UPS Healthcare is delighted to work with Fresenius Medical Care as a supply chain partner in the UK.
  • "One of the ongoing strategic priorities for Fresenius Medical Care is to constantly review and improve our operations," said Tim Wheeldon, Managing Director and Head of Fresenius Medical Care UK and Ireland.
  • Fresenius Medical Care UK has been caring for NHS kidney patients in the UK for over 20 years.

Clinical Nutrition Market - Global Outlook and Forecast 2021-2026 with Abbott Laboratories, Baxter International, B. Braun, Danone, and Nestle Health Science Dominating - ResearchAndMarkets.com

Monday, July 19, 2021 - 1:33pm

The global clinical nutrition market research report includes a detailed segmentation by route of administration, age group, product type, application, distributional channels, end-users, geography.

Key Points: 
  • The global clinical nutrition market research report includes a detailed segmentation by route of administration, age group, product type, application, distributional channels, end-users, geography.
  • Focusing on health and wellness, aging well, and disease prevention by consumers, healthcare providers are demanding preventive clinical nutrition products and are experiencing rapid growth.
  • Global brands such as Abbott, Nestle, Nutricia, and Fresenius Kabi offer parenteral, enteral, and oral nutrition products for infants.
  • Abbott Laboratories, Baxter International, B. Braun, Danone, and Nestle Health Science are the major players.

Ambulnz Launches Service in Illinois

Wednesday, July 14, 2021 - 12:20pm

With this latest expansion, Ambulnz will be able to serve 9 Fresenius Kidney Care centers in Illinois, with plans to expand coverage to an additional 50 Chicago-area clinics in the coming months.

Key Points: 
  • With this latest expansion, Ambulnz will be able to serve 9 Fresenius Kidney Care centers in Illinois, with plans to expand coverage to an additional 50 Chicago-area clinics in the coming months.
  • Ambulnz will assist people getting to and from scheduled dialysis appointments.
  • Dialysis patients in Illinois using Ambulnz services can now get dedicated and reliable transportation to and from their kidney dialysis appointments.
  • Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care.

Xenios AG receives approval in China for ECMO devices

Tuesday, July 13, 2021 - 8:51am

In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.

Key Points: 
  • In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.
  • As a result, a complete Xenios system is now permitted for ECMO therapy in China.
  • This Xenios ECMO complete system is certified in China for nine days application period.
  • The expedited approval was a joint effort by Xenios and Fresenius Medical Care China Team.

Fresenius Kabi Introduces New Simplist® Fentanyl Citrate Injection, USP 50 mcg per 1 mL in Ready-to-Administer Prefilled Syringe

Tuesday, July 6, 2021 - 2:00pm

Fresenius Kabi announced today the U.S. introduction of Fentanyl Citrate Injection, USP 50 mcg per 1 mL in its proprietary Simplist ready-to-administer prefilled syringe, the only 1 mL presentation available in the U.S. today.

Key Points: 
  • Fresenius Kabi announced today the U.S. introduction of Fentanyl Citrate Injection, USP 50 mcg per 1 mL in its proprietary Simplist ready-to-administer prefilled syringe, the only 1 mL presentation available in the U.S. today.
  • View the full release here: https://www.businesswire.com/news/home/20210706005025/en/
    Fresenius Kabi Simplist Fentanyl ready-to-administer prefilled syringes come in the proprietary MicroVault packaging system.
  • Fresenius Kabi is a leader in injectable medicines with a growing U.S. portfolio of prefilled syringes.
  • The Simplist Fentanyl prefilled syringe is manufacturer prepared in the United States, with a 24-month shelf life, and is a single-unit dose, supporting best practices for medication administration.

Fresenius Medical Care Supports Education for Healthcare Professionals in Korea With the Opening of Its First Training Center

Monday, June 28, 2021 - 2:45am

Certified trainers from Fresenius Medical Care, together with regional clinical education experts from across Asia Pacific, will provide best practice training for healthcare professionals within the renal care field.

Key Points: 
  • Certified trainers from Fresenius Medical Care, together with regional clinical education experts from across Asia Pacific, will provide best practice training for healthcare professionals within the renal care field.
  • With the opening of the Training Center, Fresenius Medical Care Korea pledges its ongoing support of healthcare professional education.
  • The Fresenius Medical Care Training Center also offers educational opportunities catering to individual healthcare professionals specializing in particular treatment modalities such as PD, HD, and CRRT.
  • The Fresenius Medical Care Training Center will provide healthcare professionals with high-standard, systematic training, helping them to advance their knowledge and skills in renal and critical care.

Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma

Thursday, June 24, 2021 - 7:00pm

Until Abbas Hussain joins the company on 16 August 2021, Stefan Schulze will continue to have overall executive responsibility for the Vifor Pharma Group.

Key Points: 
  • Until Abbas Hussain joins the company on 16 August 2021, Stefan Schulze will continue to have overall executive responsibility for the Vifor Pharma Group.
  • From 2017 to 2020, he was President of the Executive Committee and Chief Operating Officer (COO) of the Vifor Pharma Group.
  • He joined the Vifor Pharma Group in 2014 as CEO of Vifor Fresenius Medical Care Renal Pharma Ltd.
  • Jacques Theurillat, Chairman of the Board of Directors of Vifor Pharma, commented: We are delighted that Abbas Hussain, an experienced and entrepreneurial leader, will take over the helm of Vifor Pharma.